Free Newsletter
Vasella talks trends in interview
Free newsletter via e-mail
Tools
In an interview with McKinsey Quarterly, Novartis CEO Daniel Vasella identifies aging, prescription drug costs and the shift of economic power as "mega-trends" that will impact the pharma industry's future. The wide-ranging article also covers the CEO's thoughts on his management style, healthcare reform, executive compensation and more. Interview
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: